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Abstract: Usutu virus (USUV) previously restricted to Africa where it caused mild infections, 26 
emerged in 2001 in Europe and caused more severe infections among birds and humans with 27 
neurological forms, suggesting an adaptation and increasing virulence. This evolution suggests 28 
the need to better understand USUV transmission patterns for assessing risks and to develop 29 
control strategies. Phylogenetic analysis conducted in Africa showed low genetic diversity of 30 
African USUV strains except for one human and the USUV subtype (USUVsub) strains, which 31 
exhibited a deletion in the 3’UTR and nucleotide substitutions throughout the genome. Here we 32 
analyzed their viral replication in vitro in mosquito and mammalian cells, and vector competence 33 
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of Culex quinquefasciatus, compared to a reference strain. Growth kinetics of the different 34 
strains showed comparable replication rates however variations in replication and translation 35 
efficiency were observed. Vector competence analysis showed that all strains were able to infect 36 
Culex quinquefasciatus the main peridomestic Culex species in Africa, with detection of USUV 37 
viral genomes and infectious particles. Dissemination and transmission were observed only for 38 
USUVsub, but infectious particles were not detected in Culex quinquefasciatus saliva. Our 39 
findings suggest that genetic variability can affect USUV in vitro replication in a cell type-40 
dependent manner and in vivo in mosquitoes. In addition, the results show that Culex 41 
quinquefasciatus is not competent for the USUV strains analyzed here and also suggest an 42 
aborted transmission process for the USUVsub, which requires further investigations. 43 
 44 
Keywords: Usutu virus, genetic diversity, in vitro viral growth, Vector competence and Culex 45 
quinquefasciatus 46 
 47 
1. Introduction  48 
Usutu virus (USUV) is a member of the Japanese encephalitis serocomplex of the Flaviviridae 49 
family isolated for the first time in 1959 in South Africa from a Culex neavei mosquito [Woodall 50 
et al., 1963; McIntosh 1985; Poidinger et al., 1996]. USUV was reported in several African 51 
countries mainly in mosquitoes and birds [Nikolay et al., 2011]. The virus was first recognized in 52 
Europe in 2001 in association with the deaths of blackbirds (Turdus merula) and great grey owls 53 
(Strix nebulosa) in Austria [Weissenböck et al., 2002]. However, a retrospective study on 54 
paraffin-embedded tissues from dead birds found in Italy in 1996, showed detection of USUV 55 
and suggested therefore that introduction of USUV in Europe occurred prior to 2001 56 
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[Weissenböck et al., 2013]. USUV has since been reported in several European countries 57 
[Nikolay et al., 2012; Steinmetz et al., 2011].  58 
The natural transmission cycle of USUV involves mosquitoes primarily of the Culex (Cx.) genus 59 
and birds as amplifying hosts [Weissenböck  et al., 2003; Brugger et al., 2009]. The virus was 60 
detected in the wild from different mosquito species, in Senegal mainly from Cx. neavei 61 
[Nikolay et al., 2011], in Ivory Coast from Cx. quinquefasciatus [Institut Pasteur de Dakar, IPD, 62 
unpublished data] and in Kenya and Europe from Cx. pipiens [Ochieng  et al., 2013; Chvala-63 
Mannsberger et al., 2007]. Vector competence studies showed that sylvatic species, Cx. neavei in 64 
Africa [Nikolay et al., 2012] and domestic species, Cx. pipiens in Europe [Fros et al., 2015] were 65 
able to transmit USUV. 66 
Humans and other mammals such as horses, bats, dogs and wild boars can be accidental hosts 67 
[Lelli et al., 2008; Cadar  et al., 2013; Escribano-Romero et al., 2015].  In Africa, two mild cases 68 
of human infections were reported in the Central African Republic (1981) and Burkina Faso 69 
(2004) [IPD, unpublished data; Nikolay et al., 2011]. In Europe, two severe cases of 70 
neuroinvasive infections in immunocompromised patients in Italy, due to USUV, were reported 71 
for the first time in 2009 [Cavrini et al., 2009; Pecorari et al., 2009]. Since then, USUV specific 72 
IgG were detected in blood donors from Italy [Cavrini et al., 2011; Gaibani et al., 2012; 73 
Percivalle et al., 2017], and Germany [Allering et al., 2012; Cadar et al., 2017]. In 2013, three 74 
patients with neuroinvasive symptoms were also diagnosed with USUV infection in Croatia 75 
[Santini et al., 2015]. More recently, a retrospective analysis of patient material in Italy detected 76 
USUV RNA in serum as well as in cerebrospinal fluid and USUV neutralizing antibodies in 77 
serum [Grottola et al., 2017]. Another retrospective study in Montpellier showed USUV in the 78 
cerebrospinal fluid of a patient with a clinical diagnosis of idiopathic facial paralysis [Simonin et 79 
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al., 2018]. In addition, USUV was detected in human blood donors in Austria in 2017 [Bakonyi 80 
et al., 2017; Domanović et al., 2019] and 2018 [Aberle et al., 2018; Domanović et al., 2019], in 81 
Germany in 2016 [Cadar et al.; 2017; Domanović et al., 2019], in Italy in 2017-2018 [Carletti et 82 
al., 2019; Domanović et al., 2019]. All these data confirm USUV circulation in humans in 83 
Europe and its neuroinvasiveness properties.  84 
To understand the different epidemiological patterns between Africa and Europe, complete 85 
genome sequencing and phylogenetic analyses of African and European strains were done. These 86 
analyses showed overall very limited genetic diversity among all USUV strains analyzed 87 
[Nikolay et al., 2013a]. However, a subtype of USUV (USUVsub), with a large number of 88 
substitutions throughout the genome was identified and corresponds to isolate ArB1803 isolated 89 
in 1969 from Culex perfuscus in Central African Republic (CAR). In addition, another strain 90 
isolated from a human in 1981 in CAR was also identified with mutations at the 3’ non-coding 91 
region [Nikolay et al., 2013a]. 92 
USUV therefore shows limited genetic variations and geographical distribution (only in Africa 93 
and Europe) with a seemingly minor impact on public health. However, migratory birds might 94 
lead to the propagation of the virus, as seen for West Nile virus, and other members of the 95 
Japanese encephalitis serocomplex. In addition, the increasing detection and virulence in Europe 96 
suggested that USUV is becoming an emerging pathogen [Grottola et al., 2017] with potential 97 
for global emergence. 98 
For a better understanding of the transmission dynamics and preparedness against global 99 
emergence risk, the African USUV strains should be better characterized and the urban vectors 100 
capable of transmitting the virus to humans identified. Regarding the transmission of USUV to 101 
humans, Cx. quinquefasciatus seems to be the main candidate in the West African context 102 
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regarding its presence all year round, in the domestic environment and in interaction with human 103 
populations [Gowda et al., 1992]. In addition, Cx. pipiens, which is a member of the Cx. 104 
quinquefasciatus complex, is known to be the main vector of USUV in Europe [Chvala-105 
Mannsberger et al., 2007].  106 
In this regard, we analyzed here the viral replication in vitro and the vector competence of 107 
peridomestic mosquito Cx. quinquefasciatus for different USUV strains. The impact of genetic 108 
diversity between these USUV strains on viral growth and vector competence was also analyzed. 109 
Because the existing USUV specific real-time RT-PCR was not able to detect the USUVsub 110 
[Nikolay et al., 2013b], we developed a specific USUVsub RT-PCR assay in this study.  111 
2. Materials and Methods  112 
2. 1 Virus strains 113 
The USUV strains analyzed in this study were provided by the Institut Pasteur de Dakar (IPD), 114 
WHO Collaborating Center for arboviruses and viral hemorrhagic fevers (CRORA) in Senegal 115 
and are described in Table 1. Human strain (HB81P08) and USUVsub (ArB1803), which 116 
exhibited highest genetic variations [Nikolay et al., 2013a] were analyzed in comparison to the 117 
reference strain (SAAR1776). 118 
2. 2 Cells lines 119 
Three cells lines were used for viral stock preparation (C6-36 cells (Aedes albopictus)), viral 120 
stock titration (PS cells (Porcine Stable kidney cells, ATCC number, Manassas, USA) and 121 
growth kinetics (C6/36, and VERO cells (Renal epithelial cells of Cercopithecus aethiops, Sigma 122 
Aldrich, France)). These cell lines were grown with L15 medium containing 10% Foetal Bovine 123 
Serum (FBS), 1% penicillin-streptomycin, and 0.05% fungizone for mammalian and plus 10% 124 
tryptose phosphate for mosquito cells. 125 
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2. 3 Suckling mice 126 
Mice were produced in the Institut Pasteur de Dakar farm, located in Mbao, approximately 15 127 
kilometers from Dakar, Senegal. Newborn Swiss mice were placed in full-walled metal cages 128 
with a mesh lid, and a lactating female. They received a cereal-based diet and water, with a 129 
temperature between 22 and 24° C. These suckling mice from one to two days old were used for 130 
viral isolation by intracranial infection. 131 
2. 4 Mosquitoes 132 
Cx. quinquefasciatus larvae were collected from a ground pool in Barkedji (15°17N, 14°53W), a 133 
village in the northern Sahelian region of Senegal. For the infection experiments, F1 generation 134 
adult mosquitoes were reared in the laboratory by using standard methods with a temperature of 135 
27 ± 1°C, a relative humidity of 70–75%, and a 12-hour photoperiod [Gerberg et al., 1994]. 136 
2.5 Viral stock preparation 137 
For in vitro kinetic experiments viral stocks were prepared by infecting C6-36 cells with the 138 
different USUV strains (Table 1) for 4 days. To assess the cells infection by USUV, 139 
immunofluorescence assay (IFA) was done as described previously [Digoutte et al., 1992, 140 
Nikolay 2012]. Briefly, cells were dissolved in PBS and dropped on a glass slide. After complete 141 
drying, cells were fixed in cold acetone, dried again, and then stored at -20°C until staining. 142 
Staining was done with a USUV-specific polyclonal mouse immune ascit (polyclonal mouse 143 
immune ascites produced with the whole inactivated USUV reference strain) diluted in PBS1X 144 
as first antibody. Then cells were incubated with the second antibody (1/40 goat anti-mouse IgG, 145 
1/100 Evan’s blue, diluted in PBS1X). Examination was done by fluorescence microscopy. 146 
For vector competence analysis, viral stocks were prepared by intracerebral infection of suckling 147 
mice in order to reach high viral titers. Five days after the inoculation, the mice presented 148 
7 
 
symptoms of infection and the brains were recovered and homogenized into L15 medium. The 149 
presence of USUV in the brain homogenates was tested by reverse transcription - quantitative 150 
polymerase chain reaction (RT-PCR) as previously described [Nikolay et al., 2012]. 151 
The different viral stocks (from cells or suckling mice) were aliquoted and frozen at -80°C for 152 
further experiments. For growth kinetics and mosquito infection experiments viral stocks were 153 
titrated as previously described, using PS cells [De Madrid et Porterfield 1969; Nikolay et al., 154 
2012; Fall et al., 2014]. The plaque sizes of the different strains were also analyzed. 155 
2.6 Growth kinetics 156 
The growth kinetics were done as previously described [Stock et al., 2013; Fall et al., 2017]. 157 
Briefly, mammalian VERO and mosquito C6-36 cells in culture were infected in 12-well plate (1 158 
plate for 1 strain) with a multiplicity of infection (MOI) of 0.01. For each plate, supernatant and 159 
cells were harvested after 22, 28, 50, 75, 99, 124, and 146 hours post infection. Supernatants 160 
were analyzed by titration and RT-PCR and the cells by IFA as previously described [Stock et 161 
al., 2013; Fall et al., 2017]. The cells were analyzed by IFA assays to estimate the production of 162 
viral antigens and RT-PCR assays to measure the viral RNA replication inside the cells while the 163 
supernatants were analyzed by RT-PCR to estimate the number of viral particles released, and by 164 
titration to measure the number of infectious particles. Finally, we estimated the replication 165 
efficiency by calculating the ratio of the number of total released particles in the supernatant 166 
divided by the number of plaque forming units (PFU), for each time point and cell line 167 
[Weidmann et al., 2011]. 168 
Strain growth rates were compared using the R software (R version 3.3.2, The R Foundation for 169 
Statistical Computing) using the Kruskal Wallis test, which permits to compare strains 170 
replication in pairs at each sampling time (significant when p-value was less than 0.05). 171 
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2.7 Oral infection of mosquitoes 172 
Oral infections were performed as already described [Nikolay et al., 2012; Fall et al., 2014; 173 
Ndiaye et al., 2016]. Briefly, female mosquitoes were exposed to an infectious blood meal 174 
containing the different USUV strains and the remaining blood meal was titrated. The 175 
mosquitoes were then cold anesthetized and the engorged mosquitoes were selected and 176 
incubated at 28°C, with relative humidity of 70–80% and fed with sucrose at 10% for 15 days. A 177 
second oral infection was done when less than 30 mosquitoes were engorged during the first oral 178 
infection. To follow the evolution of infection and dissemination over time, specimens were 179 
collected and killed, frozen at 4, 8, and 12 days post-feeding (dpf). For each mosquito, both legs 180 
and wings were placed in one tube and the body in another separate tube. At day 15 post-181 
infection, the remaining mosquitoes were collected and each mosquito was processed separately 182 
to collect legs/wings, bodies and saliva as previously described [Nikolay et al., 2012; Fall et al., 183 
2014; Ndiaye et al., 2016]. All samples were stored at −80°C until testing. 184 
2.8 Analysis of mosquito samples  185 
Each mosquito sample was tested for the presence of USUV by RT-PCR and IFA. The bodies 186 
were first screened by RT-PCR followed by legs and wings of mosquitoes with positive bodies, 187 
and saliva when legs and wings were positive [Nikolay et al., 2012; Fall et al., 2014].  188 
Viral isolation was done in C6-36 cells to show presence of infectious particles by IFA in RT-189 
PCR positive samples as well as to amplify low tittered samples. Negative samples were 190 
passaged up to 3 times to confirm their negativity.  191 
Samples were considered positive when they were detected by RT-PCR and confirmed by IFA. 192 
The rates of infection (number of positive bodies/ number of tested mosquitoes), dissemination 193 
(number of positive legs-wings/ number of positive bodies) and transmission (number of positive 194 
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saliva/ number of positive legs-wings) were compared using R software (R version 3.3.2). The 195 
transmission rates estimated here by analyzing the positive saliva correspond to the potential or 196 
transmissible mosquito infection rates.  197 
2.9 RNA extraction and real time RT-PCR 198 
Extraction of viral RNA from supernatants and cell suspension was performed with the QIAamp 199 
viral RNA mini kit (Qiagen, Heiden, Germany) according to manufacturer’s instructions. Cells 200 
were lysed by serial cycles of freeze/thaw before RNA extraction. 201 
For the detection and quantification of viral RNA, a consensus USUV real-time RT-PCR assay 202 
and corresponding RNA standard targeting the NS5 gene was used for SAAR1776 and HB81P08 203 
strains, as previously described [Nikolay et al., 2013b] (Table 2). This Usutu virus specific real-204 
time RT-PCR was not able to detect USUVsub [Nikolay et al., 2013b], we therefore additionally 205 
developed specific set of primers and probe for USUVsub also targeting the NS5 sequence 206 
(Table 2).  207 
Both primers and probes systems were synthesised (TIB Mol-Biol, Berlin, Germany) and tested.  208 
The real-time PCR assays were performed using the Quantitect Probe RT-PCR Kit (Qiagen, 209 
Heiden, Germany) in a 96-well plate under the following conditions: 50°C for 15 min, 95°C for 210 
15 min followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. Copy numbers of genome 211 
were calculated using Ct (Cycle threshold) and corresponding RNA standard. 212 
2.10 Development of USUVsub RT-PCR assay 213 
2.10.1 Standard RNA for USUVsub 214 
Primers 1803 NS5 F1 (CCGAGGACAGGATGAACTCA) and 1803 NS5 R1 215 
(TGGCCTGACATTCCTACACT) (TIB Molbiol, Berlin, Germany) designed in this study were 216 
used to amplify the NS5 gene (650bp) of the USUVsub. Reverse transcription was done using 217 
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the AMV kit (Invitrogen, Carlsbad USA) and the 1803 NS5 R1 primer, following the provider’s 218 
instructions. The resulting complementary DNA was amplified using Go-Taq PCR kit (Promega, 219 
Madison, USA) and the PCR conditions are the following: 5 min 94 °C, 45cycles of 1 min 94 °C, 220 
1 min 53 °C and 1 min 72°C, and 10 min 72°C. The RNA standard was synthetized at TIB 221 
Molbiol with the PCR product obtained as previously described [Fall et al., 2016]. 222 
2.10.2 Determination of analytical specificity and sensitivity  223 
Ten-fold dilutions of the RNA standard with known copy number were quantified in triplicate 224 
using the USUVsub primers and probe. Regression curves were obtained representing the RNA 225 
copy number/reaction vs the threshold cycle value (Ct). The lowest RNA copy number with RT-226 
PCR detection was considered as the analytical detection limit. 227 
In parallel, ten-fold dilutions in L15-medium of a viral stock of USUVsub with a known viral 228 
infectious titer was similarly quantified in triplicate and the lowest number of infectious virus 229 
particles with RT-PCR detection was considered as the analytical detection limit in serum. 230 
The specificity of the assay was determined by testing other USUV strains, and flaviviruses West 231 
Nile, Zika, yellow fever and dengue strains (Table 3). The amplification efficiency of the primers 232 
was calculated from the slope of the standard regression lines (E=101/slope −1). 233 
 234 
2.11 Secondary structure analysis 235 
VISUALOMP version 7 and FORNA (force-directed RNA) were used to predict and fold the 236 
RNA secondary structures at 37°C and 20°C [Kerpedjiev et al., 2015]. 237 
3. Results 238 
3.1 Viral stocks 239 
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For in vitro kinetic experiments, the viral stocks were prepared in C6/36 cells and the following 240 
titers were observed: 4.25x107pfu/ml, 2x104 pfu/ml and 3x105pfu/ml, respectively for 241 
SAAR1776, HB81P08 and ArB1803.  242 
For mosquito infections, higher viral titers were needed and the viral stocks were prepared in 243 
suckling mice. The following higher titers were observed:  3.5x1010pfu/ml, 3x1010pfu/ml and 244 
1.35x109pfu/ml, respectively for SAAR1776, HB81P08 and ArB1803.  245 
The USUVsub showed small plaques size while other USUV strains showed greater plaques in 246 
PS cells with viral stocks prepared both in C6/36 cells and in suckling mice (Figure 1).  247 
3.2 Validation of USUV subtype RT-PCR assay 248 
RNA from different USUV and other flavivirus strains had been previously tested and 249 
successfully detected by Pan-Flavi primers and probe RT-PCR assay [Patel et al., 2013]. The 250 
USUVsub RT-PCR assay did not detect other USUV strains or cross-detect other flaviviruses 251 
like yellow fever, dengue, West Nile and Zika viruses (Table 3).  252 
The analytical detection limit of the RT-PCR assay tested with the RNA standard was 100 253 
copies/ reaction.  In addition, the detection limit was tested with the viral stock in L-15 medium 254 
and was 45 pfu/ reaction. Efficiencies ranged from 91 to 94.5% (Figure 2). 255 
3.3 Growth kinetics 256 
In Vero cells, regarding the intra-cellular replication, all the strains had comparable genome 257 
replication (p-values= 0.12-0.8) (Figure 3, panel A) while variations were observed for the 258 
antigen production (Figure 3, panel D). Indeed, the reference and human strains had greater 259 
antigen production rates and the USUVsub had lower rates from 99 to 146 hpi (p-values =0.03-260 
0.04). Analyses of supernatants showed statistically comparable total released (Figure 3, panel 261 




infectious virions (pfu) showed that in mammalian cells, the reference and the human strains 263 
presented lower ratios, producing about as many genome copies as infectious particles, while 264 
USUVsub showed higher ratios showing overproduction of genome copies (p-values= 0.04) 265 
(Figure 4, panel A). 266 
In C6/36 cells, regarding the intra-cellular replication, the USUVsub showed significant 267 
differences in the genome replication and antigen production (Figure 3, panels E and H). Indeed, 268 
the USUVsub led to higher genome copy numbers from 28 to 50h pi (p-values= 0.04) and lower 269 
genome copy numbers from 99 to 126h pi (p-values= 0.04). The antigen production was 270 
comparable for all strains except at 75 and 99h pi where USUVsub showed lower production 271 
rates (p-values= 0.04). Analyses of supernatants showed also that all strains had statistically 272 
comparable total released (Figure 3, panel F) and infectious particles (Figure 3, panel G) (p-273 
values > 0.05). In mosquito cells, the ratio of genome copy number / infectious virions (pfu) for 274 
all strains were comparable (p-values= 0.12 - 0.82) (Figure 4). 275 
The USUVsub developed much smaller plaques in mammalian PS cells compared to other 276 
strains, similar to the original viral stock plaque sizes (Figure 1). 277 
3.4 Vector competence of Cx. quinquefasciatus mosquitoes  278 
For the HB81P08 strain, one infection was done and the viral titer post feeding was (pfe) 4.5x 279 
107 pfu/ml. RT-PCR tests detected infection rates of 50, 16.66 and 40% for 8, 12 and 15 dpi 280 
respectively. IFA tests confirmed the infection rates for 8 and 12 dpi while at 15 dpi only 33.33% 281 
of the samples were confirmed. No virus was detected in the legs/wings with both methods 282 
(Figure 5, column 3). 283 
One experimental infection was done for strain SAAR1776, and the blood meal titer post feeding 284 




12 and 15 dpi respectively (Figure 5, column 4). IFA tests did not confirm infection at 4 dpi 286 
while 40, 20 and 18.46% of tested samples were confirmed at 8, 12, and 15 dpi respectively. For 287 
the dissemination, RT-PCRs tests of the legs/wings gave rates of 20%, 0% and 20.68% at 8, 12, 288 
and 15 dpi (Figure 5). In contrast, IFA showed negative results for all the RT-PCR positive 289 
legs/wings and did not confirm viral dissemination (Figure 5). 290 
For USUVsub (ArB1803), two experimental infections were done; the blood meal contained 291 
5.75x107 and 3.25x106 pfu/ml. RT-PCRs tests detected infection rates between 40 to 50% at 4, 8 292 
and 12 dpi for experiment 2. Infection rates were 19.51% and 38.70% at 15 dpi for experiments 1 293 
and 2 respectively (Figure 5, columns A and B). However, IFA tests confirmed only 5 % of 294 
infection at 4 dpi and 20% at 8 and 12 dpi. For 15 dpi, 15.85% and 29.03% were confirmed 295 
respectively for both infections (Figure 5, upper panels columns A and B). Dissemination was 296 
shown for this strain by RT-PCR with rates of 30 and 44.44% at 4 and 8 dpi. The virus was not 297 
detected in the mosquito’s legs-wings at 12 dpi. Dissemination rates were 58.33% and 18.75% at 298 
15dpi for experiments 1 and 2 respectively (Figure 5, middle panels columns A and B). IFA tests 299 
confirmed dissemination only at 15 dpi with rates of 7.69% and 55.55% for both experiments 300 
(Figure 5). Transmission rates estimated by RT-PCR tests were 42.85% and 33.33% at 15 dpi for 301 
both experiments (Figure 5, lower panels columns A and B). The corresponding viral genome 302 
copy numbers in these positive salivas were determined using the RNA standard developed in 303 
this study and ranged between 1042 to 3232 per ml. However, no infectious particles were 304 
detected in the saliva samples by IFA and therefore the transmission of the USUVsub was not 305 
confirmed.  306 
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The statistic tests for equality of proportions showed no difference in the infection capabilities of 307 
reference, human and USUVsub strains (SAAR1776, HB81P08, and ArB1803) by RT-PCR as 308 
well as by with p-values of 0.88 and 0.80 respectively.  309 
4. Discussion 310 
Here we investigated growth behavior in vitro in mosquito (C6/36) and primate (Vero) cell lines 311 
as well as in vivo in Cx. quinquefasciatus of 3 distinct USUV strains. We chose primate and 312 
mosquito cell lines to mimic vector and vertebrate hosts in the natural life cycle of USUV. We 313 
found that genetic differences, as well as viral-mosquito interactions, probably play a role in the 314 
biological properties such as: (i) genome replication, (ii) protein translation, and (iii) 315 
susceptibility to infect and disseminate in mosquitoes. 316 
We first developed a real time RT-PCR assay for USUVsub detection. The analytical sensitivity 317 
of the previously described USUV assay (60 copies/ reaction) was comparable to the sensitivity 318 
of the USUVsub assay developed in this study (100 copies/ reaction) [Nikolay et al., 2013b]. For 319 
the detection of corresponding viral particles, the detection limit of the RT-PCR assay was 1.2 320 
pfu/ reaction with the USUV assay and 45 pfu/ reaction for the USUVsub assay [Nikolay et al., 321 
2013b]. In addition, the USUVsub assay showed good specificity and was not able to detect 322 
other USUV or flavivirus strains.  323 
Analyzing RT-PCR and plaque assay results, USUVsub appeared to overproduce genomes 324 
(Figure 4A) resulting in viral particles with reduced infectivity, indicating defective particles due 325 
to less efficient packaging [Weidmann et al., 2011]. While the reference and the human strains 326 
were more efficient in producing infectious particles (Figure 3C). The infectious particles 327 
produced by USUVsub were down at least 1 log in comparison to the other two strains. In 328 




The human and the reference USUV strains showed similar replication rates in both cell lines, 331 
meaning that the mutations at the 3’ non-coding region of the human strain did not impact on its 332 
replication in vitro with the cell lines used for this study.  333 
A phylogenetic study done by Nikolay and colleagues revealed that the NS5 protein, which has 334 
RNA-dependent polymerase and methyltransferase activity [Danecek et al., 2010], was the most 335 
conserved region of USUV strains [Nikolay et al., 2013a]. This could explain the comparable 336 
replication rates for human and reference USUV strains. Similar results were also observed for 337 
different West Nile virus strains in mammalian (VERO) and mosquito (AP61) cells [Fall et al., 338 
2017]. For USUVsub, substitutions located in the NS5 protein and also in other genome regions 339 
led probably to the observed variations cell type-dependent [Nikolay et al., 2013a]. Indeed, in 340 
C6/36 cells, minor replication rate variations were detected while in mammalian cells, delay on 341 
protein translation was clearly measurable for USUVsub. In addition, this strain showed lower 342 
lysis plaque sizes during viral titrations on mammalian PS cells irrespective of previous culture 343 
in mice or on C6/36 cells. Recently it was shown that Zika virus strains isolated from humans 344 
display large plaques on mammalian cells and small plaques on C6/36 cells, which was seen as a 345 
host effect i.e. essentially adaptation to the host from which they were isolated (Moser et al 346 
2018). Similarly USUVsub originally isolated from the mosquito Culex perfuscus did produce 347 
only small plaques on mammalian PS cells. This correlates quite well with the out of sync 348 
production of a low number of infectious particles of USUVsub in mammalian Vero cells (Fig. 349 





Reference and human strains have already been characterized in mice and results showed 353 
comparable mortality when applied by the intracerebral route, however in intraperitoneal and 354 
subcutaneous routes, the reference strain showed higher virulence and mortality [Diagne et al., 355 
2019]. These data suggest that depending on the infection route, the mutations at the 3’ non-356 
coding region of the human strain had a negative impact on its replication and virulence in vivo 357 
in mice. Therefore, further studies with mice models are needed to better explore and understand 358 
the virulence of the USUVsub compared to the other strains. 359 
We also performed a vector competence study of Cx. quinquefasciatus, an anthropophagic and 360 
competent peridomestic vector for West Nile and Rift Valley fever viruses in Africa [Fall et al., 361 
2014; Ndiaye et al., 2016], in order to better understand the USUV transmission cycle. Our result 362 
showed that Cx. quinquefasciatus is susceptible to all USUV strains analyzed, while 363 
dissemination in the mosquito legs and wings was observed only for USUVsub. In mosquito 364 
saliva, we were able to detect viral RNA for USUVsub only, however, no infectious viral 365 
particles were found. These results demonstrate that Culex quinquefasciatus from Senegal was 366 
not able to transmit the USUV strains analyzed here. 367 
In Senegal, Nikolay and colleagues [Nikolay et al., 2012] showed that the mosquito Cx. neavei 368 
was able to transmit the USUV reference strain using a blood meal titer, which did not exceed 369 
4.5x106 pfu/ml. In our study we infected Cx. quinquefasciatus mosquitoes with the same strain 370 
with 5x106 pfu/ml and for the others strains even higher viral titers (HB81P08: 4.5x107pfu/ml, 371 
ArB1803: 3.25x106 to 5.75x107 pfu/ml) were used. In Europe, to investigate vector competence 372 
of Cx. pipiens, belonging to the same complex as Cx. quinquefasciatus, Fros and colleagues 373 
performed their oral infection with 50% tissue culture infectious dose (TCID50) of 4x10
7 per ml 374 
[Fros et al., 2015] and for Aedes albopictus 0.66x107.5 / 0.66x107.9 TCID50/ml were used 375 
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[Puggioli et al., 2017]. All these studies used viral titers comparable to those obtained in our 376 
study, so the viral titers used did not affect their transmission by Cx. quinquefasciatus.   377 
The human and reference strains had similar infection profiles, we therefore assumed that the 378 
mutations at the 3’ non-coding region of the human strain did not impact its replication in 379 
mosquitoes.  380 
Although there was no transmission, USUVsub seemed to be more adapted to Cx 381 
quinquefasciatus than the other strains. Indeed, USUVsub infectious particles were detected in 382 
mosquito bodies and legs/wings while for other strains, the infectious particles were limited to 383 
the mosquito bodies even if viral RNA was detected in legs/wings. These differences in the 384 
mosquito infection patterns could be explained by the genetic variability of the virus strains used 385 
in our experiment. The numerous substitutions observed in the USUVsub genome might increase 386 
its fitness in Cx. quinquefasciatus. Similar studies done with West Nile virus also showed the 387 
impact of genetic variability on Cx. quinquefasciatus infection patterns [Fall et al., 2014]. 388 
More studies could be done to better characterize this USUVsub genetic variability in order to 389 
better understand the role and nature of genetic substitutions to mosquito infection. In recent 390 
years the role of secondary structures in the 3’UTR of flavivirus genomes and the number and 391 
length of subgenomic flavivirus RNAs (sfRNAs) coded for in this region have been shown to be 392 
relevant for host specificity [Slonchak et al., 2018]. Differences in secondary structure have been 393 
linked to adaptation and transmission by mosquitoes [Yeh et al., 2018; Villordo et al., 2015; 394 
Moser et al., 2018]. Secondary structure analysis indicates that the predicted secondary structures 395 
for the 3’UTR of USUVsub differ significantly from those described so far (Figure S1). This 396 
difference may be related to the observed efficient replication of USUVsub in the mosquito cells 397 
in vivo but needs further investigation beyond the scope of this study. 398 
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Combining RT-PCR and IFA showed that many viral particles produced during the mosquito 399 
infection are defective (Figure 5). Indeed, all the viral particles detected by RT-PCR in the 400 
different mosquito compartments, were not confirmed by IFA, this latter technique allowing the 401 
detection of viral infectious particles. Our results suggest that the viral infection process of Cx. 402 
quinquefasciatus with USUV strains was aborted and only defective viral particles were released 403 
in mosquito legs/wings for the reference strain and into the saliva for USUVsub. This indicates 404 
that there is no USUV transmission by Cx. quinquefasciatus and more studies are needed to 405 
better understand the abortion of USUV viral infection in the legs/wings and saliva of Cx. 406 
quinquefasciatus. These results highlight the need to include virus isolation and IFA in vector 407 
competence analysis to prove that RNA detected by RT-PCR corresponds to infectious viral 408 
particles that could replicate in a vertebrate host after transmission during a mosquito blood 409 
meal. 410 
In Senegal the circulation of USUV is monitored by entomological surveillance at Pasteur 411 
Institute of Dakar, which showed a circulation of the virus mainly in Cx neavei species until 412 
2016 [CRORA database, IPD unpublished data; Nikolay et al., 2011]. The virus has never been 413 
isolated from Cx quinquefasciatus in the field, and experimentally we confirmed that this 414 
mosquito species is not able to transmit USUV. Although the reference strain showed virulence 415 
and induced mortality in vertebrate hosts [Gaibani et al., 2012, Diagne et al., 2019], the absence 416 
of transmission by Cx. quinquefasciatus could explain the lack of USUV human cases in Senegal 417 
and West Africa. However, vector competence studies with others mosquito species in Africa 418 
should be done to better investigate the urban transmission of USUV.  419 
5. Conclusions 420 
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The low genetic diversity described for USUV [Nikolay et al., 2013a] had a minor impact in 421 
vitro and a significant impact in vivo in the mosquito Cx. quinquefasciatus even if this mosquito 422 
species was not able to transmit the virus. Among the strains analyzed in this study, USUVsub 423 
was the most divergent. Further complementary studies using mouse model would allow us to 424 
better understand the pathogenicity of this strain. 425 
As evidenced by Zika virus, the epidemiology of infectious diseases depends on climatic, 426 
ecological and human related factors. Just 2 sporadic non-severe USUV cases in humans have 427 
been described in Africa [Cavrini et al., 2009; Pecorari et al., 2009; Busani et al., Ochieng et al., 428 
2013; Cadar et al., 2017]. However, in Europe, severe cases of human infections have been 429 
detected. Therefore, more vector competence studies for USUV are needed to identify competent 430 
peridomestic vectors. In addition, entomological, animal reservoir and human surveillance need 431 
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Table 1: Strains used in this study 602 
Three different USUV strains were used in this study. Geographic origins, year of isolation, host 603 
and accession numbers are indicated. 604 
* Ap3/NBM3/C61 is equivalent to 3 serial passages in Ap61 (Ap) followed by 2 passages in 605 











OF PASSAGES  




SAAR1776  South Africa  1959  Culex neavei        7  AP3/NBM3/C61  AY453412  
ArB1803  Central African Republic  1969  Culex perfuscus        7  AP3/NBM3/C61  KC754958  

























Table 2: Primers and probes used in this study 630 
Primers and probes used in this study are indicated in this table. The USUV assay previously 631 
developed [Nikolay et al., 2013b] permits the detection of reference and human strains and the 632 
USUVsub assay developed in this study allows the detection of USUVsub.  633 
 634 
Primers and probes  Sequences  Region  
Usu FP  (USUV)  5’- CAAAGCTGGACAGACATCCCTTAC  NS5  
Usu RP  (USUV)  5’- CGTAGATGTTTTCAGCCCACGT  NS5  
Usu P  (USUV)  5’- 6FAM-AAGACATATGGTGTGGAAGCCTGATAGGCA--TMR  NS5  
NF FP  (USUVsub)  5’- AGAGCTGGACGGAAGTTCCCTA  NS5  
NF RP  (USUVsub)  5’- TCTCAGCCCATGTTGCACG  NS5  
NF P  (USUVsub)  5’- 6FAM-AAGAGAGAAGACATTTGGTGCGGCAGT—TMR  NS5  
1803 NS5 F1 (USUVsub)  5’- CCGAGGACAGGATGAACTCA  NS5  















Table 3: Specificity of the USUV subtype RT-PCR 647 
USUV and different flaviviruses strains were used to analyze the specificity of the USUVsub 648 
RT-PCR assay. The PanFlavi assay previously developed [Patel et al., 2013] were used to 649 
confirm presence of viral RNA in all the samples. The geographic origin, the host origin and the 650 
year of isolation of each strain were indicated in this table. 651 
 652 
 653 






ArB1803 USUVsub  Central African  Republic  Culex perfuscus  1969 31.55 21.74 
SAAR1776 USUV  South Africa  Culex neavei  1959 26.17 - 
HB81P08 USUV  Central African Republic  Human  1981 25.52 - 
ArD101291  USUV  Senegal  Culex gr. univittatus  1993 24.67 - 
259524 USUV  Senegal  Mastomys natalensis  2013 25.79 - 
259520 USUV  Senegal  Mastomys natalensis  2013 25.83 - 
FNV 281  Yellow fever  Ghana  Human  1927 20.46 - 
New Guinea C  Dengue2  New Guinea  Human  1974 24.61 - 
MR766  Zika  Uganda  Rhesus monkey  1947 28.02 - 
B956 WNV  Uganda  Human  1937 32.91 - 
Eg101 WNV  Egypt  Human  1951 35.69 - 
ArD166362 WNV  Senegal  Aedes vexans  2002 37.41 - 
Dak ArB209  Bagaza  Central African Republic  Culex spp.  1966 23.74 - 
ArB490  Bouboui  Central African Republic  Anopheles paludis  1967 23.48 - 
ArD14701  Kedougou  Senegal  Aedes minutis  1972 29.06 - 
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 660 
Figure 1: Titration of USUV strains. Shows the plaques obtained during USUV titration with PS 661 
cells. 662 
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Figure 2: Sensitivity of the USUV subtype RT-PCR assay. (A): Serial 10-fold dilutions of in 689 
vitro RNA standard have been tested in the corresponding real-time RT-PCR assay. Tested 690 
dilutions ranged from 1 × 108 to 1 copies/reaction for the RNA standard of the USUVsub specific 691 
real-time RT-PCR assay. (B): Serial 10-fold dilutions of virus in L-15 medium have been tested 692 
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for USUVsub real-time RT-PCR assay. Tested dilutions ranged from 4.5x105 to 4.5 pfu for the 693 







Figure 3: Growth kinetics of different strains of USUV mammalian (VERO) and in mosquitoe 701 
(C6/36) cells. Amount of viral RNA equivalents isolated from cells (A and E) and from 702 
supernatant (B and F) (log10 of RNA copy number), the number of infectious viral particles (C 703 
and G) (log10 PFU/ml), and percentage of immunofluorescence of cells infected (D and H), and 704 
at 22, 28, 50, 75, 99, 124 and 146 hours pi. The experiments were performed with C6/36 cells 705 







Figure 4: Replication efficiency of USUV in mosquitoes (C6/36) and mammalian (VERO) cells. 711 
Replication efficiency (Log particles/PFU/mL) of USUV strains in VERO (A) and C6/36 (B) 712 














Figure 5:  qRT-PCR and Indirect Immunofluorescence Assay (IFA) of bodies, legs-wings and 724 
saliva of mosquitoes infected with different strains of USUV. 725 
Infection rates, dissemination rates and transmission rates of mosquitoes Cx. quinquefasciatus 726 
infected with USUV strains at days 4, 8, 12 and 15 pi. All rates were estimated with RT-PCR 727 
and IFA tests. The numbers above the bars represent the total number of individuals tested in 728 
each day of sampling for each strain. 729 
 730 
